← back to search

Levent Akyüz

Berlin Institute of Health at Charité - Universitätsmedizin Berlin · DE
Area of research
Genetics · Oncology
Research interest
Research interests include Mesenchymal stem cell research, CAR-T cell therapy research, HIV Research and Treatment, and Immune Response and Inflammation.
h-index
14
citations
1,390
works
29
NIH funding
primary concept
email

Recent publications

ILOBONE: A phase I/IIa randomized controlled trial to assess the safety and feasibility of local iloprost therapy for enhancing proximal humerus fracture healing– a pilot study design
Journal of Orthopaedic Surgery and Research 2025cited by 2position: middledoi
Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells
Molecular Therapy — Methods & Clinical Development 2022cited by 91position: middledoi
Interleukin 8 in postoperative delirium – Preliminary findings from two studies
Brain Behavior & Immunity - Health 2022cited by 17position: middledoi
Intramuscular and intratendinous placenta‐derived mesenchymal stromal‐like cell treatment of a chronic quadriceps tendon rupture
Journal of Cachexia Sarcopenia and Muscle 2022cited by 6position: middledoi
Physostigmine for prevention of postoperative delirium and long-term cognitive dysfunction in liver surgery
European Journal of Anaesthesiology 2021cited by 50position: middledoi
Diagnostic biomarkers for adult haemophagocytic lymphohistiocytosis in critically ill patients (HEMICU): a prospective observational study protocol
BMJ Open 2019cited by 50position: middledoi
High-fat Diet and Physical Exercise Differentially Modulate Adult Neurogenesis in the Mouse Hypothalamus
Neuroscience 2018cited by 44position: middledoi
Indomethacin promotes survival of new neurons in the adult murine hippocampus accompanied by anti-inflammatory effects following MPTP-induced dopamine depletion
Journal of Neuroinflammation 2018cited by 36position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Claudia Spies · University Hospital Ulm3 papers (2019–2022)Hans‐Dieter Volk · Humboldt-Universität zu Berlin3 papers (2019–2022)Sophie K. Piper · Humboldt-Universität zu Berlin2 papers (2019–2021)Cornelia Knaak · Humboldt-Universität zu Berlin2 papers (2019–2021)Petra Reinke · Humboldt-Universität zu Berlin2 papers (2022–2022)Barbara Steiner · Group for the Analysis of Development2 papers (2018–2018)Lennard Ostendorf · Brigham and Women's Hospital1 papers (2022–2022)Georg Winterer · Apple (Israel)1 papers (2022–2022)Johann Pratschke · Johnson & Johnson (United States)1 papers (2021–2021)Anna Shadenok · Berlin Institute of Health at Charité - Universitätsmedizin Berlin1 papers (2021–2021)Clarissa von Haefen · Humboldt-Universität zu Berlin1 papers (2019–2019)Jochen Kruppa · Osnabrück University1 papers (2019–2019)Armin Rehm · Charité - Universitätsmedizin Berlin1 papers (2022–2022)Tobias Braun · Medizinische Hochschule Hannover1 papers (2022–2022)Fatima Yürek · Berlin Institute of Health at Charité - Universitätsmedizin Berlin1 papers (2022–2022)Stefania Martini · Humboldt-Universität zu Berlin1 papers (2022–2022)Cornelia Lachmann · Humboldt-Universität zu Berlin1 papers (2022–2022)E. Wesley Ely · Vanderbilt University1 papers (2021–2021)C Klein · Friedrich-Loeffler-Institut1 papers (2018–2018)Charlotte Klein · University of Freiburg1 papers (2018–2018)